Everolimus plus R-­CHOP as initial therapy for DLBCL: a phase I/feasibility study (NCCTG N1085 [Alliance])
      Google Scholar   
Citation:
Hematol Oncol vol 33 (suppl S2) p 241, abstr 282
Meeting Instance:
ICML 2015
Year:
2015
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Primary
Analysis:
Preliminary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
2456  
Program:
OGC
Primary Committee:
Lymphoma
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, CA025224  
Corr. Author:
 
Authors:
                   
Networks:
LAPS-MN026   
Study
NCCTG-N1085
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
1
Keywords: